Screener
Corning GLW Life Sciences and Emerging Growth Businesses — Segment assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Corning in its filing.
Tagged under the XBRL concept us-gaap:AssetsNet.
The source filing: Corning’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 12:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000024741-26-000255
| June 30, 2026 | Optical Communications | Glass Innovations | Automotive | Solar | Total Reportable Segments | Life Sciences and Emerging Growth Businesses | Total |
|---|---|---|---|---|---|---|---|
| Investment in affiliated companies | $5 | $112 | — | — | $117 | $156 | $273 |
| Segment assets (1) | $4,737 | $9,240 | $2,335 | $3,029 | $19,341 | $1,424 | $20,765 |
| December 31, 2025 | |||||||
| Investment in affiliated companies | $5 | $114 | — | — | $119 | $183 | $302 |
| Segment assets (1) | $4,029 | $9,236 | $2,395 | $2,734 | $18,394 | $1,470 | $19,864 |
Item 1. Financial Statements
FAQ
- What is Corning's life sciences and emerging growth businesses — segment assets?
- Corning (GLW) reported life sciences and emerging growth businesses — segment assets of $1.42B in Q2 2026.
- What does life sciences and emerging growth businesses — segment assets mean?
- This metric measures the total value of assets directly attributable to the Life Sciences and Emerging Growth segment, including inventory, property, plant, and equipment. It provides a view of the capital base required to support the segment's operations. Analyzing this helps determine the asset turnover and efficiency of the segment.
Ask your AI about Corning's life sciences and emerging growth businesses — segment assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude